The secretion of IL-1β, IL-6, IL-8, SDF-1, and NFκB by CAFs contributes to immune cell recruitment that may contribute to tumor progression, cancer survival and drug resistance by creating a protective niche in the TME [67,68]. This evidence concerns the gene IL6 and cancer.